GKIRX | HBLTX | GKIRX / HBLTX | |
Total Expense Ratio | 0.57 | 0.66 | 86% |
Annual Report Gross Expense Ratio | 0.71 | 0.66 | 108% |
Fund Existence | 15 years | 15 years | - |
Gain YTD | 3.878 | 4.039 | 96% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 0 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 2.54B | 11.8B | 22% |
Annual Yield % from dividends | 4.31 | 3.56 | 121% |
Returns for 1 year | 8.42 | 4.71 | 179% |
Returns for 3 years | 29.22 | 16.62 | 176% |
Returns for 5 years | 36.40 | 17.41 | 209% |
Returns for 10 years | 66.21 | 39.57 | 167% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
SBHIX | 22.96 | -0.10 | -0.43% |
Saratoga Health & Biotechnology I | |||
DEMZX | 24.57 | -0.29 | -1.17% |
Macquarie Emerging Markets R6 | |||
HHDFX | 35.38 | -0.43 | -1.20% |
Hamlin High Dividend Equity Instl | |||
PICEX | 7.13 | -0.09 | -1.25% |
Virtus SGA Emerging Markets Equity C | |||
AIGIX | 21.39 | -0.30 | -1.38% |
Alger International Opportunities I |